Back to today’s briefing

Story perspectives

Pfizer, Arcos Dorados, Academy Sports Announce Growth Plans

10/5/2025

40 8 Full Breakdown

Summary

Story summary

Pfizer signs a deal with the Trump administration to lower drug prices and boost U.S. manufacturing; 6% revenue growth expected from 2025–2030.
Arcos Dorados, Latin America's largest independent McDonald's franchisee, reports 15% currency-adjusted revenue growth and a 3.5% dividend yield.
Academy Sports plans 150 new locations by 2028, targeting double-digit growth and a 1% dividend yield.

History

Historical Context

The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 expanded drug coverage, allowing pharmaceutical companies like Pfizer, which reported $51.8 billion in revenue that year, to set prices with minimal regulation. Recent efforts, including a deal with the Trump administration, aim to lower drug prices, reflecting ongoing tensions between the pharmaceutical industry and government regulations over healthcare costs.

1 of 2

Story summary

Pfizer signs a deal with the Trump administration to lower drug prices and boost U.S. manufacturing; 6% revenue growth expected from 2025–2030.
Arcos Dorados, Latin America's largest independent McDonald's franchisee, reports 15% currency-adjusted revenue growth and a 3.5% dividend yield.
Academy Sports plans 150 new locations by 2028, targeting double-digit growth and a 1% dividend yield.

1 / 2